(Q54505605)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682022%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

title

Randomized phase 2b trial of tofacitinib (CP-690,550) in de novo kidney transplant patients: efficacy, renal function and safety at 1 year (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682022%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

0 references

1 reference

ChEBI release 2020-05-28

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682022%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Klemens Budde

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682022%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

F Vincenti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682022%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

H Tedesco Silva

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682022%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

S Busque

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682022%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

P O'Connell

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682022%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

D Cibrik

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682022%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

A Yoshida

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682022%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

S Cohney

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682022%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

W Weimar

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682022%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Y S Kim

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682022%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

N Lawendy

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682022%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

S-P Lan

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682022%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

E Kudlacz

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682022%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

S Krishnaswami

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682022%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

G Chan

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682022%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

language of work or name

English

0 references

publication date

8 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682022%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Transplantation

4 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682022%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682022%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682022%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

2446-2456

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682022%20AND%20SRC:MED&resulttype=core&format=json

Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era.

4 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04127.X

The natural history of chronic allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04127.X

Sirolimus in kidney transplantation indications and practical guidelines: de novo sirolimus-based therapy without calcineurin inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04127.X

Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04127.X

mTOR inhibition: the learning curve in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04127.X

Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo kidney allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04127.X

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04127.X

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04127.X

Reduced exposure to calcineurin inhibitors in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04127.X

The change in allograft function among long-term kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04127.X

Post-transplant renal function in the first year predicts long-term kidney transplant survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04127.X

Effect of histological damage on long-term kidney transplant outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04127.X

Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04127.X

Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04127.X

The aetiology and pathogenesis of chronic allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04127.X

The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04127.X

A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04127.X

Long-term graft survival with neoral and tacrolimus: a paired kidney analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04127.X

Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04127.X

Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04127.X